Zevra Therapeutics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

ZVRA
Zevra Therapeutics

Last Price:

9.15

Seasonality Move:

6.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Zevra Therapeutics Stock Forecast

Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 13.3% based on the past 9 years of stock performance.
Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Is Zevra Therapeutics Stock Undervalued?
The current Zevra Therapeutics [ZVRA] share price is $9.13. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Zevra Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 13.3% based on the past 9 years of stock performance.

Zevra Therapeutics Stock Rating

Buy

Zevra Therapeutics (ZVRA) is a Buy

Is Zevra Therapeutics overpriced?

Zevra Therapeutics has fallen lower in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Zevra Therapeutics Stock Price History

Is ZVRA stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

zevra.com

52-Week Data

52-Week High:

9.30

52-Week Low:

4.20

Prediction Charts

Market Cap:

487.32M

Price in USD:

9.13

Volume:

458.22K

Beta:

1.81

Technical Analysis

SMA50:

8.15

SMA100:

7.41

SMA200:

6.34

52-Wk Change:

102.44%

Stock Predictions

Is Zevra Therapeutics stock public?
Yes, Zevra Therapeutics is a publicly traded company.
What is the Zevra Therapeutics stock quote today?
The Zevra Therapeutics stock price is 9.13 USD today.
How to buy Zevra Therapeutics stock online?
You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-4	8.32	8.55	8.67	8.22
Nov-5	8.54	8.61	8.65	8.26
Nov-6	8.70	8.80	8.91	8.60
Nov-7	8.88	8.81	9.03	8.67
Nov-8	8.81	9.00	9.04	8.65
Nov-11	9.02	8.95	9.04	8.76
Nov-12	8.91	8.57	9.09	8.35
Nov-13	8.08	8.64	8.80	7.84
Nov-14	8.35	9.03	9.21	8.35
Nov-15	9.10	8.62	9.17	8.32
Nov-18	8.62	8.60	8.69	8.33
Nov-19	8.60	8.97	9.13	8.53
Nov-20	9.09	8.97	9.27	8.71
Nov-21	9.04	9.13	9.30	8.90

Zevra Therapeutics Earnings

Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Zevra Therapeutics Forecast Revenue Growth

Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.

* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.